Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 2, 1999, Pages 107-113

  Dong, Krista L ^a   Bausserman, Linda L ^a   Flynn, Mary M ^a   Dickinson, Brian P ^a   Flanigan, Timothy P ^a   Mileno, Maria D ^a   Tashima, Karen T ^a   Carpenter, Charles C J ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

Author keywords

HAART; HIV in women; Hyperlipidemia; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BREAST AUGMENTATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADIPOSE TISSUE; ADULT; ANTI-HIV AGENTS; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INSULIN; LIPIDS; MIDDLE AGED; TIME FACTORS; TRIGLYCERIDES; WEIGHT GAIN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033153014     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
2. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA panel. JAMA 1998;280:78-86.
3. Bartlett JG, Fauci AS, Goosby EP, Smith MD. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47(No.RR-5):43-82.
4. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. JAMA 1997;277:145-53.
5. Collier AC, Coombs RW, Schoenfeld DA, et al. For the AIDS Clinical Trials Group. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. N Engl J Med 1996;334:1011-7.
6. Lipsky JJ. Abnormal fat accumulation in patients with HIV-1 infection. Lancet 1998;351:847-8.
7. Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS 1998;12:F37-F39.
8. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving protease inhibitors. AIDS 1998;12:F51-8.
9. Miller KD, Jones E, Yanovski JA, et al. Visceral abdominal fat accumulation associated with use of indinavir. Lancet 1998;351: 871-5.
10. Lo JC, Mulligan K, Tai VW, et al. "Buffalo-hump" in men with HIV-1 infection. Lancet 1998;351:867-70.
11. Roth VR, Angel S, Kravcik S. Development of a cervical fat pad following treatment with HIV-1 protease inhibitors [abstract 411]. Vth Conference on Retroviruses and Opportunistic Infections, Chicago, February 1-5, 1998.
12. Anderson AJ, Sobocinski KA, Freedman DS, et al. Body fat distribution, plasma lipids and lipoproteins. Arteriosclerosis 1998;9: 88-94.
13. Kissebah AH, Peiris AN, Evans D. Mechanisms associating body fat distribution to glucose intolerance and diabetes: window with a view. Acta Med Scand 1987;723(Suppl):79-89.
14. Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 1992;24:15-8.
15. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter; best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-8.
16. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984;289:1257-61.
17. Folsom AR, Kage SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA 1993;269:483-7.
18. Lean ME, Han RS, Seidel JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998;351: 853-6.
19. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993;153:2209-16.
20. 2) and triceps skin-fold thickness. Am J Clin Nutr 1991;53:839-46.
21. Allain CC, Poon LS, Chan CSG. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
22. Kohlmeier M. Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin Chem 1986;32:63-6.
23. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23: 1206-23.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18: 513-7.
25. Smith DK, Warren D, Solomon L, et al. for the HER Study Group. The design, participants and selected early findings of the HIV epidemiologic research (HER) study: a prospective cohort study of the impact of HIV infection on the health of American women. In: Women and AIDS: coping and caring. New York: Plenum Press, 1996:185-205.
26. Kuchmak M, Taylor L, Olansky AS. Suitability of frozen and lyophilized reference sera for cholesterol and triglyceride determinations. Clin Chin Acta 1982;120:261-7.
27. Laboratory Methods Committee of the Lipid Research Clinics Program of the National Heart, Lung, and Blood Institute. Cholesterol and triglyceride concentrations in serum plasma pairs. Clin Chem 1977;23:60-3.
28. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 1991;325:373-81.
29. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiala AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641-6.
30. Freedman DS, Jacobsen SJ, Barboriak JJ, et al. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 1990;81:1498-1506.
31. Kratz A, Lewandrowski KB. Normal reference laboratory values. N Engl J Med 1998;339:1063-72.
32. Grunfeld C, Pang M, Doeffler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74: 1045-52.
33. Carr A, Samaras K. Chisholm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia and insulin resistance. Lancet 1998;351:1881-3.